Development and validation of the functional assessment of cancer therapy–antiangiogenesis subscale

The Functional Assessment of Cancer Therapy (FACT)–Antiangiogenesis (AntiA) Subscale was developed and validated to enhance treatment decision-making and side effect management for patients receiving anti-angiogenesis therapies. Side effects related to anti-angiogenesis therapies were identified fro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Kaiser, Karen, Beaumont, Jennifer L, Webster, Kimberly, Yount, Susan E, Wagner, Lynne I, Kuzel, Timothy M, Cella, David
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BlackWell Publishing Ltd 2015
Pynciau:
Cancer Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430262/
https://ncbi.nlm.nih.gov/pubmed/25619758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.385
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg